Full Press Release Details
ALTERITY THERAPEUTICS
Monday February 17, 2025
The +securities to be quoted are:
+Securities issued as part of a transaction or transactions previously announced to the market in an Appendix 3B
number of +securities to be quoted
| ASX +security code | Security description | Number of +securities to be quoted | Issue date | |||
| ATH | ORDINARY FULLY PAID | 1,165,841,830 | 17/02/2025 |
to next page for full details of the announcement
Entity and announcement details
THERAPEUTICS LIMITED
We (the entity named above) apply for +quotation of the following +securities and agree to the matters set out in Appendix 2A of the ASX
| 1.2 Registered number type | Registration number | ||
| ABN | 37080699065 |
Date of this announcement
The +securities to be quoted are:
+Securities issued as part of a transaction or transactions previously announced to the market in an Appendix 3B
Previous Appendix 3B details:
| Announcement Date and Time | Announcement Title | Selected Appendix 3B to submit quotation request | |||
| 10-Feb-2025 10:25 | New - Proposed issue of securities - ATH | A placement or other type of issue |
2.3a.2 Are there any further issues of +securities yet to take place to complete
the transaction(s) referred to in the Appendix 3B?
2.3a.3 Please provide
details of the further issues of +securities yet to take place to complete the transaction(s) referred to in the Appendix 3B
Part 3A - number and type of +securities to be quoted where issue has previously been notified to ASX in an Appendix 3B
ASX +security code and description
: ORDINARY FULLY PAID
Distribution Schedule
Provide a distribution schedule for the new +securities according to the categories set out in the left hand column - including the number
of recipients and the total percentage of the new +securities held by the recipients in each category.
| Total percentage of +securities held | |||||
| Number of +securities held | Number of holders | For example, to enter a value of 50% | |||
| please input as 50.00 | |||||
| 1 - 1,000 | % | ||||
| 1,001 - 5,000 | % | ||||
| 5,001 - 10,000 | % | ||||
| 10,001 - 100,000 | % | ||||
| 100,001 and over | % |
Number of +securities to be quoted
the +securities being issued for a cash consideration?
| In what currency is the cash consideration being paid? | What is the issue price per +security? | ||
| AUD - Australian Dollar | AUD 0.01100000 |
other information the entity wishes to provide about the +securities to be quoted
Part 4 - Issued capital following quotation
the quotation of the +securities the subject of this application, the issued capital of the entity will comprise:
The figures in parts 4.1 and 4.2 below are automatically
generated and may not reflect the entity's current issued capital if other Appendix 2A, Appendix 3G or Appendix 3H forms are currently
with ASX for processing.
Quoted +securities (total number of each +class of +securities quoted on ASX following the +quotation of the +securities subject of this
| ASX +security code and description | Total number of +securities on issue | ||
| ATH : ORDINARY FULLY PAID | 6,656,848,719 | ||
| ATHO : OPTION EXPIRING 31-AUG-2026 | 932,611,430 |
4.2 Unquoted +securities (total number of each +class of +securities issued but not quoted on ASX)
| ASX +security code and description | Total number of +securities on issue | ||
| ATHAAE : OPTION EXPIRING 29-NOV-2026 EX $0.0375 | 14,250,000 | ||
| ATHAAG : OPTION EXPIRING 29-NOV-2026 EX $0.0238 | 11,900,000 | ||
| ATHAAB : OPTION EXPIRING 17-SEP-2025 EX $0.09 | 35,000,000 | ||
| ATHAAK : OPTION EXPIRING 30-DEC-2027 EX $0.01 | 170,000,000 | ||
| ATHAAH : OPTION EXPIRING 19-DEC-2026 EX $0.0105 | 8,000,000 | ||
| ATHAB : OPTION EXPIRING 13-MAR-2029 EX US$0.0031 | 62,500,000 | ||
| ATHAA : OPTION EXPIRING 13-MAR-2029 EX $0.004 | 20,166,667 | ||
| ATHAC : OPTION EXPIRING 21-MAR-2029 EX US$0.003 | 120,000,000 | ||
| ATHAAD : OPTION EXPIRING 06-JAN-2026 EX $0.032 | 91,392,720 |